205 related articles for article (PubMed ID: 22093497)
1. The optimal cutoff serum level of human chorionic gonadotropin for efficacy of methotrexate treatment in women with extrauterine pregnancy.
Sagiv R; Debby A; Feit H; Cohen-Sacher B; Keidar R; Golan A
Int J Gynaecol Obstet; 2012 Feb; 116(2):101-4. PubMed ID: 22093497
[TBL] [Abstract][Full Text] [Related]
2. Multidose Methotrexate Treatment of Ectopic Pregnancies with High initial β-Human Chorionic Gonadotropin: Can Success Be Predicted?
Tug N; Sargin MA; Yassa M
Gynecol Obstet Invest; 2019; 84(1):56-63. PubMed ID: 30099453
[TBL] [Abstract][Full Text] [Related]
3. Role of initial and day 4 human chorionic gonadotropin levels in predicting the outcome of single-dose methotrexate treatment in women with tubal ectopic pregnancy.
Ustunyurt E; Duran M; Coskun E; Ustunyurt ÖB; Simşek H
Arch Gynecol Obstet; 2013 Nov; 288(5):1149-52. PubMed ID: 23666603
[TBL] [Abstract][Full Text] [Related]
4. Medical management of ectopic pregnancy with single-dose and 2-dose methotrexate protocols: human chorionic gonadotropin trends and patient outcomes.
Mergenthal MC; Senapati S; Zee J; Allen-Taylor L; Whittaker PG; Takacs P; Sammel MD; Barnhart KT
Am J Obstet Gynecol; 2016 Nov; 215(5):590.e1-590.e5. PubMed ID: 27371354
[TBL] [Abstract][Full Text] [Related]
5. Predictors of methotrexate treatment failure in ectopic pregnancy.
Dilbaz S; Caliskan E; Dilbaz B; Degirmenci O; Haberal A
J Reprod Med; 2006 Feb; 51(2):87-93. PubMed ID: 16572908
[TBL] [Abstract][Full Text] [Related]
6. Comparison of alternative βhCG follow-up protocols after single-dose methotrexate therapy for tubal ectopic pregnancy.
Şükür YE; Koyuncu K; Seval MM; Çetinkaya E; Dökmeci F
Arch Gynecol Obstet; 2017 Dec; 296(6):1161-1165. PubMed ID: 28932897
[TBL] [Abstract][Full Text] [Related]
7. βhCG monitoring after single-dose methotrexate treatment of tubal ectopic pregnancy: is the Day 4 βhCG necessary? A retrospective cohort study.
Atkinson M; Gupta S; Mcgee T
Aust N Z J Obstet Gynaecol; 2014 Oct; 54(5):475-9. PubMed ID: 25287565
[TBL] [Abstract][Full Text] [Related]
8. [Medical treatment of unruptured ectopic pregnancy].
Rojas Mora E; Hernández Vivar LE; Sánchez Contreras J; Risco Cortés RJ; Pulido Olivares VH
Ginecol Obstet Mex; 2004 Apr; 72():135-41. PubMed ID: 15318753
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of expectant management versus methotrexate in tubal ectopic pregnancy: a double-blind randomized trial.
Silva PM; Araujo Júnior E; Cecchino GN; Elito Júnior J; Camano L
Arch Gynecol Obstet; 2015 Apr; 291(4):939-43. PubMed ID: 25315383
[TBL] [Abstract][Full Text] [Related]
10. A risk prediction model for medical treatment failure in tubal pregnancy.
Lee JH; Kim S; Lee I; Yun J; Yun BH; Choi YS; Lee BS; Seo SK
Eur J Obstet Gynecol Reprod Biol; 2018 Jun; 225():148-154. PubMed ID: 29727784
[TBL] [Abstract][Full Text] [Related]
11. Single-dose methotrexate for the treatment of unruptured ectopic pregnancy.
Erdem M; Erdem A; Arslan M; Oç A; Biberoğlu K; Gürsoy R
Arch Gynecol Obstet; 2004 Dec; 270(4):201-4. PubMed ID: 12955534
[TBL] [Abstract][Full Text] [Related]
12. Intramuscular methotrexate for tubal pregnancy.
el-Lamie IK; Shehata NA; Kamel HA
J Reprod Med; 2002 Feb; 47(2):144-50. PubMed ID: 11883354
[TBL] [Abstract][Full Text] [Related]
13. Predictive factors for the methotrexate treatment outcome in ectopic pregnancy: A comparative study of 400 cases.
Bonin L; Pedreiro C; Moret S; Chene G; Gaucherand P; Lamblin G
Eur J Obstet Gynecol Reprod Biol; 2017 Jan; 208():23-30. PubMed ID: 27888702
[TBL] [Abstract][Full Text] [Related]
14. Predictors of success of methotrexate treatment in women with tubal ectopic pregnancies.
Lipscomb GH; McCord ML; Stovall TG; Huff G; Portera SG; Ling FW
N Engl J Med; 1999 Dec; 341(26):1974-8. PubMed ID: 10607814
[TBL] [Abstract][Full Text] [Related]
15. Cutoff value of human chorionic gonadotropin in relation to the number of methotrexate cycles in the successful treatment of ectopic pregnancy.
Nowak-Markwitz E; Michalak M; Olejnik M; Spaczynski M
Fertil Steril; 2009 Oct; 92(4):1203-1207. PubMed ID: 18851850
[TBL] [Abstract][Full Text] [Related]
16. Single-dose methotrexate injection for treatment of ectopic pregnancy in women with relatively low levels of human chorionic gonadotropin.
Krissi H; Peled Y; Eitan R; Bishara A; Goldchmit C; Ben-Haroush A
Int J Gynaecol Obstet; 2013 May; 121(2):141-3. PubMed ID: 23465854
[TBL] [Abstract][Full Text] [Related]
17. Management of ectopic pregnancies with poor prognosis through ultrasound guided intrasacular injection of methotrexate, series of 14 cases.
Andrés MP; Campillos JM; Lapresta M; Lahoz I; Crespo R; Tobajas J
Arch Gynecol Obstet; 2012 Feb; 285(2):529-33. PubMed ID: 21837423
[TBL] [Abstract][Full Text] [Related]
18. Predictors of success of methotrexate treatment in women with tubal ectopic pregnancies.
Mol BW; Hajenius PJ; van der Veen F
N Engl J Med; 2000 Apr; 342(15):1138. PubMed ID: 10766587
[No Abstract] [Full Text] [Related]
19. Methotrexate treatment for tubal pregnancy. Criteria for medical approach.
Cobellis G; Pierno G; Pecori E; Scaffa C; Stradella L; Messalli EM; Festa B; Cobellis L
Minerva Ginecol; 2003 Dec; 55(6):531-5. PubMed ID: 14676743
[TBL] [Abstract][Full Text] [Related]
20. Predictors of success in methotrexate treatment of women with unruptured tubal pregnancies.
Nazac A; Gervaise A; Bouyer J; de Tayrac R; Capella-Allouc S; Fernandez H
Ultrasound Obstet Gynecol; 2003 Feb; 21(2):181-5. PubMed ID: 12601843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
